Insilico Medicine

Insilico Medicine is a biotechnology company headquartered in Boston, Massachusetts, with additional facilities in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, and in New York, at The Cure by Deerfield. Source

Category
Software
Headquarters
Hong Kong, China
Founded
2014

Insilico Medicine across Glyph

Insilico Medicine across Glyph: timeline

  1. Official Careers: insilico.com/careers (Socials)
  2. Official Blog: insilico.com/blog (Socials)
  3. Official Instagram: @insilicomedicine (Socials)
  4. Official Facebook: insilicomedicine (Socials)
  5. Official YouTube: InsilicoMedicine (Socials)
  6. Official LinkedIn: in-silico-medicine-inc (Socials)
  7. Official X: @InSilicoMeds (Socials)
  8. Rentosertib trial data read out on six proteomic aging clocks (Emerging)
  9. Insilico Medicine: IPO $293M (Emerging)
  10. Nature Medicine publishes Phase 2a trial of AI-discovered drug rentosertib (Emerging)
  11. Insilico reports positive Phase 2a results for its AI-designed IPF drug (Emerging)

Sources